Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap

被引:134
作者
Lacaille, Diane [1 ,2 ]
Avina-Zubieta, J. Antonio [1 ,2 ]
Sayre, Eric C. [1 ]
Abrahamowicz, Michal [3 ]
机构
[1] Arthritis Res Canada, Richmond, BC, Canada
[2] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada
[3] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
关键词
MODIFYING ANTIRHEUMATIC DRUGS; ACUTE MYOCARDIAL-INFARCTION; CLINICAL COMORBIDITY INDEX; CARDIOVASCULAR MORTALITY; STATIN DISCONTINUATION; SYSTEMIC INFLAMMATION; EXCESS MORTALITY; INCEPTION COHORT; DISEASE; RISK;
D O I
10.1136/annrheumdis-2016-209562
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective Excess mortality in rheumatoid arthritis (RA) is expected to have improved over time, due to improved treatment. Our objective was to evaluate secular 5-year mortality trends in RA relative to general population controls in incident RA cohorts diagnosed in 1996-2000 vs 2001-2006. Methods We conducted a population-based cohort study, using administrative health data, of all incident RA cases in British Columbia who first met RA criteria between January 1996 and December 2006, with general population controls matched 1: 1 on gender, birth and index years. Cohorts were divided into earlier (RA onset 1996-2000) and later (2001-2006) cohorts. Physician visits and vital statistics data were obtained until December 2010. Follow-up was censored at 5 years to ensure equal follow-up in both cohorts. Mortality rates, mortality rate ratios and HRs for mortality (RA vs controls) using proportional hazard models adjusting for age, were calculated. Differences in mortality in RA versus controls between earlier and later incident cohorts were tested via interaction between RA status (case/control) and cohort (earlier/later). Results 24 914 RA cases and controls experienced 2747 and 2332 deaths, respectively. Mortality risk in RA versus controls differed across incident cohorts for all-cause, cardiovascular diseases (CVD) and cancer mortality (interactions p<0.01). A significant increase in mortality in RA versus controls was observed in earlier, but not later, cohorts (all-cause mortality adjusted HR (95% CI): 1.40 (1.30 to 1.51) and 0.97 (0.89 to 1.05), respectively). Conclusions In our population-based incident RA cohort, mortality compared with the general population improved over time. Increased mortality in the first 5 years was observed in people with RA onset before, but not after, 2000.
引用
收藏
页码:1057 / 1063
页数:7
相关论文
共 77 条
[1]
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study [J].
Avina-Zubieta, J. Antonio ;
Abrahamowicz, Michal ;
De Vera, Mary A. ;
Choi, Hyon K. ;
Sayre, Eric C. ;
Rahman, M. Mushfiqur ;
Sylvestre, Marie-Pierre ;
Wynant, Willy ;
Esdaile, John M. ;
Lacaille, Diane .
RHEUMATOLOGY, 2013, 52 (01) :68-75
[2]
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study [J].
Avina-Zubieta, J. Antonio ;
Abrahamowicz, Michal ;
Choi, Hyon K. ;
Rahman, M. Mushfiqur ;
Sylvestre, Marie-Pierre ;
Esdaile, John M. ;
Lacaille, Diane .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :990-995
[3]
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].
Avina-Zubieta, J. Antonio ;
Choi, Hyon K. ;
Sadatsafavi, Mohsen ;
Etminan, Mahyar ;
Esdaile, John M. ;
Lacaille, Diane .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697
[4]
BC Vital Statistics Agency, 2011, VIT STAT DEATHS POP
[5]
Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden [J].
Bergstrom, Ulf ;
Jacobsson, Lennart T. H. ;
Turesson, Carl .
RHEUMATOLOGY, 2009, 48 (12) :1600-1605
[6]
Björnådal L, 2002, J RHEUMATOL, V29, P906
[7]
British Columbia Ministry of Health, 2012, MED SERV PLAN MSP PA
[8]
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs [J].
Bykerk, Vivian P. ;
Akhavan, Pooneh ;
Hazlewood, Glen S. ;
Schieir, Orit ;
Dooley, Anne ;
Haraoui, Boulos ;
Khraishi, Majed ;
Leclercq, Sharon A. ;
Legare, Jean ;
Mosher, Diane P. ;
Pencharz, James ;
Pope, Janet E. ;
Thomson, John ;
Thorne, Carter ;
Zummer, Michel ;
Bombardier, Claire .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) :1559-1582
[9]
Rheumatoid arthritis [J].
Carmona, Loreto ;
Cross, Marita ;
Williams, Ben ;
Lassere, Marissa ;
March, Lyn .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2010, 24 (06) :733-745
[10]
Chang J, 2011, ARTHRITIS RHEUM-US, V63, pS49